|
US4985461A
(en)
|
1985-10-21 |
1991-01-15 |
Rohm And Haas Company |
Insecticidal N'-substituted-N,N'-diacylhydrazines
|
|
US5117057A
(en)
|
1985-10-21 |
1992-05-26 |
Rohm And Haas Company |
Insecticidal N' substituted-N-N'-disubstituted-hydrazines
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
FR2593630B1
(fr)
|
1986-01-27 |
1988-03-18 |
Maurice Francois |
Ecran d'affichage a matrice active a resistance de drain et procedes de fabrication de cet ecran
|
|
US5225443A
(en)
|
1986-05-01 |
1993-07-06 |
Rohm And Haas Company |
Insecticidal N'-substituted-N'-substituted N,N'-diacylhydrazines
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5283173A
(en)
|
1990-01-24 |
1994-02-01 |
The Research Foundation Of State University Of New York |
System to detect protein-protein interactions
|
|
AU655417B2
(en)
|
1990-03-22 |
1994-12-22 |
Salk Institute For Biological Studies, The |
Insect retinoid receptor compositions and methods
|
|
CA2043775A1
(en)
|
1990-06-14 |
1991-12-15 |
Dat P. Le |
Dibenzoylakylcyanohydrazines
|
|
ATE159548T1
(de)
|
1990-11-13 |
1997-11-15 |
Immunex Corp |
Bifunktionelle wählbare fusionsgene
|
|
IL100643A
(en)
|
1991-01-25 |
1996-10-31 |
Nippon Kayaku Kk |
History of hydrazine and pesticides containing these histories as an active ingredient
|
|
US6013836A
(en)
|
1992-02-28 |
2000-01-11 |
Rohm And Haas Company |
Insecticidal N'-substituted-N,N'-disubstitutedhydrazines
|
|
US5530028A
(en)
|
1992-11-23 |
1996-06-25 |
Rohm And Haas Company |
Insecticidal N'-substituted-N,N'-diacylhydrazines
|
|
US5350674A
(en)
|
1992-09-04 |
1994-09-27 |
Becton, Dickinson And Company |
Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof
|
|
AU6953394A
(en)
|
1993-05-21 |
1994-12-20 |
Targeted Genetics Corporation |
Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
|
|
FR2705686B1
(fr)
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
|
CA2144040A1
(fr)
|
1993-07-13 |
1995-01-26 |
Michel Perricaudet |
Vecteurs adenoviraux defectifs et utilisation en therapie genique
|
|
WO1995016772A1
(en)
|
1993-12-14 |
1995-06-22 |
Cornell Research Foundation, Inc. |
Adenovirus gene expression system
|
|
US5851806A
(en)
|
1994-06-10 |
1998-12-22 |
Genvec, Inc. |
Complementary adenoviral systems and cell lines
|
|
EP0784690B1
(en)
|
1994-06-10 |
2006-08-16 |
Genvec, Inc. |
Complementary adenoviral vector systems and cell lines
|
|
US5998205A
(en)
|
1994-11-28 |
1999-12-07 |
Genetic Therapy, Inc. |
Vectors for tissue-specific replication
|
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
|
DE69634630T2
(de)
|
1995-03-03 |
2005-11-10 |
Syngenta Participations Ag |
Kontrolle der pflanzengenexpression durch rezeptor-vermittelte transaktivation in gegenwart von einem chemischen ligand
|
|
DE69633565T3
(de)
|
1995-06-15 |
2013-01-17 |
Crucell Holland B.V. |
Verpackungssysteme für humane, menschliche adenoviren, zur verwendung in die gentherapie
|
|
AUPN443995A0
(en)
|
1995-07-27 |
1995-08-17 |
Csl Limited |
Papillomavirus polyprotein
|
|
US5837511A
(en)
|
1995-10-02 |
1998-11-17 |
Cornell Research Foundation, Inc. |
Non-group C adenoviral vectors
|
|
US6001622A
(en)
|
1995-12-21 |
1999-12-14 |
Sunnybrook Health Science Centre |
Integrin-linked kinase and its use
|
|
US5885827A
(en)
|
1996-01-23 |
1999-03-23 |
The Regents Of The Universtiy Of California |
Eukaryotic high rate mutagenesis system
|
|
EP0910652B1
(en)
|
1996-04-05 |
2014-10-08 |
The Salk Institute For Biological Studies |
Hormone-mediated methods for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
|
DK0973928T3
(da)
|
1997-03-11 |
2010-08-09 |
Univ Minnesota |
DNA-baseret transposonsystem til indføring af nukleinsyre i DNA i en celle
|
|
AU738494B2
(en)
|
1997-07-10 |
2001-09-20 |
Salk Institute For Biological Studies, The |
Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression
|
|
US6333318B1
(en)
|
1998-05-14 |
2001-12-25 |
The Salk Institute For Biological Studies |
Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
|
US6113913A
(en)
|
1998-06-26 |
2000-09-05 |
Genvec, Inc. |
Recombinant adenovirus
|
|
US6225289B1
(en)
|
1998-12-10 |
2001-05-01 |
Genvec, Inc. |
Methods and compositions for preserving adenoviral vectors
|
|
WO2001030965A2
(en)
|
1999-10-28 |
2001-05-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of in vivo gene transfer using a sleeping beauty transposon system
|
|
WO2001051528A1
(en)
|
2000-01-12 |
2001-07-19 |
Eastman Chemical Company |
Procatalysts comprising bidentate ligands, catalyst systems, and use in olefin polymerization
|
|
WO2001070816A2
(en)
|
2000-03-22 |
2001-09-27 |
Rohm And Haas Company |
Ecdysone receptor-based inducible gene expression system
|
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
|
ATE320493T1
(de)
|
2000-06-22 |
2006-04-15 |
Ucb Pharma Ltd |
Modifizierung des hepatitis b kernantigens
|
|
US8105825B2
(en)
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
|
CA2438119C
(en)
|
2001-02-20 |
2014-12-16 |
Rheogene Holdings, Inc. |
Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
|
|
ES2385598T3
(es)
|
2001-02-20 |
2012-07-27 |
Intrexon Corporation |
Sistema novedoso de expresión génica inducible basado en el receptor de ecdisona/receptor X retinoide de invertebrado
|
|
EP1534738B1
(en)
|
2001-02-20 |
2012-06-20 |
Intrexon Corporation |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
AU2002306550B2
(en)
|
2001-02-20 |
2007-10-25 |
Intrexon Corporation |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
WO2003020879A2
(en)
|
2001-07-23 |
2003-03-13 |
Genvec, Inc. |
Cells and methods for propagating adenoviral vectors
|
|
US6677156B2
(en)
|
2001-07-23 |
2004-01-13 |
Genvec, Inc. |
Non-adenoviral gene product-based complementing cells for adenoviral vectors
|
|
US6682929B2
(en)
|
2001-07-23 |
2004-01-27 |
Genvec, Inc. |
Adenovector complementing cells
|
|
EP1425045A4
(en)
|
2001-09-13 |
2004-11-10 |
Genvec Inc |
ADENOVIRAL VECTOR AND RELEVANT SYSTEM AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
JP2005532781A
(ja)
|
2001-09-26 |
2005-11-04 |
レオジーン・ホールディングス,インコーポレーテッド |
ヨコバイエクジソン受容体核酸、ポリペプチド、およびそれらの使用
|
|
EP1490686A2
(en)
|
2001-09-26 |
2004-12-29 |
RheoGene Holdings Inc. |
Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
|
|
WO2003089618A2
(en)
|
2002-04-22 |
2003-10-30 |
Regents Of The University Of Minnesota |
Transposon system and methods of use
|
|
US7375093B2
(en)
|
2002-07-05 |
2008-05-20 |
Intrexon Corporation |
Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
|
PT1572233E
(pt)
|
2002-12-20 |
2011-06-07 |
Glaxosmithkline Biolog Sa |
Utilização de hpv16 e hpv18 como vacina contra um ou mais de tipos de hpv oncogénicos 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
|
|
US7304161B2
(en)
|
2003-02-10 |
2007-12-04 |
Intrexon Corporation |
Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
|
|
US7304162B2
(en)
|
2003-02-21 |
2007-12-04 |
Intrexon Corporation |
Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
|
US7456315B2
(en)
|
2003-02-28 |
2008-11-25 |
Intrexon Corporation |
Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
|
US7985739B2
(en)
|
2003-06-04 |
2011-07-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enhanced sleeping beauty transposon system and methods for using the same
|
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
PT2360255E
(pt)
|
2005-03-25 |
2015-04-08 |
Nat Res Council Canada |
Método para isolamento de polipéptidos solúveis
|
|
WO2007073513A2
(en)
|
2005-11-10 |
2007-06-28 |
Genvec, Inc. |
Method for propagating adenoviral vectors encoding inhibitory gene products
|
|
WO2008051854A2
(en)
|
2006-10-20 |
2008-05-02 |
Trustees Of Boston University |
A tunable genetic switch for regulating gene expression
|
|
JP5675109B2
(ja)
|
2007-02-20 |
2015-02-25 |
アナプティスバイオ インコーポレイティッド |
ライブラリーの生成方法及びその使用
|
|
MX363066B
(es)
|
2007-05-29 |
2019-03-07 |
Intrexon Corp |
Ligandos quirales de diacilhidrazina para modular la expresion de genes exogenos por medio de un complejo receptor de ecdisona.
|
|
GB0710538D0
(en)
|
2007-06-01 |
2007-07-11 |
Glaxo Group Ltd |
Vaccine
|
|
US9228180B2
(en)
|
2007-07-04 |
2016-01-05 |
Max-Delbruck-Centrum Fur Molekulare Medizin |
Polypeptide variants of sleeping beauty transposase
|
|
US20090136465A1
(en)
|
2007-09-28 |
2009-05-28 |
Intrexon Corporation |
Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses Thereof
|
|
JP2010539993A
(ja)
|
2007-10-08 |
2010-12-24 |
イントレキソン コーポレーション |
遺伝子操作した樹状細胞および癌の治療のための使用
|
|
MX340972B
(es)
|
2008-10-08 |
2016-08-02 |
Intrexon Corp |
Celulas manipuladas por ingenieria que expresan multiples inmunomoduladores, y uso de las mismas.
|
|
EP2550359B1
(en)
|
2010-03-23 |
2017-08-09 |
Intrexon Corporation |
Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof
|
|
PE20140844A1
(es)
|
2011-02-12 |
2014-07-14 |
Globeimmune Inc |
Terapeuticos a base de levadura para infeccion de la hepatitis b cronica
|
|
EP2681327B1
(en)
|
2011-03-04 |
2018-11-21 |
Intrexon Corporation |
Vectors conditionally expressing protein
|
|
KR102067760B1
(ko)
|
2011-08-16 |
2020-01-17 |
삼성전자주식회사 |
세포 내 전달용 단백질 복합체 및 그의 용도
|
|
BR112014008167B1
(pt)
|
2011-10-05 |
2022-05-24 |
Genvec Inc |
Adenovírus ou vetor adenoviral e composição os compreendendo
|
|
CA2851251C
(en)
|
2011-10-05 |
2023-09-12 |
Genvec, Inc. |
Simian (gorilla) adenovirus or adenoviral vectors and methods of use
|
|
CA2850627C
(en)
|
2011-10-05 |
2024-05-21 |
Genvec, Inc. |
Affenadenovirus (gorilla) or adenoviral vectors and methods of use
|
|
WO2013053008A2
(en)
|
2011-10-14 |
2013-04-18 |
The Walter And Eliza Hall Institute Of Medical Research |
Molecules which bind clec9a
|
|
CN104159607A
(zh)
|
2012-01-24 |
2014-11-19 |
桑福德研究院/南达科他大学 |
用于治疗致癌病毒多肽阳性肿瘤的多核苷酸
|
|
EP2855511B1
(en)
*
|
2012-05-29 |
2019-07-24 |
GenVec, Inc. |
Herpes simplex virus vaccine
|
|
SG11201604781RA
(en)
|
2013-12-18 |
2016-07-28 |
Intrexon Corp |
Single chain il-12 nucleic acids, polypeptids, and uses thereof
|
|
WO2015106281A1
(en)
|
2014-01-13 |
2015-07-16 |
Baylor Research Institute |
Novel vaccines against hpv and hpv-related diseases
|
|
CN107073070A
(zh)
|
2014-08-15 |
2017-08-18 |
格纳西尼有限公司 |
治疗宫颈癌的方法
|
|
SG11201702295UA
(en)
|
2014-09-22 |
2017-04-27 |
Intrexon Corp |
Improved therapeutic control of heterodimeric and single chain forms of interleukin-12
|
|
JP6775515B2
(ja)
|
2015-03-11 |
2020-10-28 |
ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム |
トランスポザーゼポリペプチド及びその使用
|
|
EP3138579A1
(en)
|
2015-09-05 |
2017-03-08 |
Biomay Ag |
Fusion protein for use in the treatment of a hepatitis b virus infection
|
|
AU2016334401A1
(en)
|
2015-10-10 |
2018-04-26 |
Intrexon Corporation |
Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
|
|
CA3001351A1
(en)
|
2015-10-21 |
2017-04-27 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating hepatitis b virus
|
|
WO2017083750A1
(en)
|
2015-11-11 |
2017-05-18 |
Intrexon Corporation |
Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies
|
|
CN108601951B
(zh)
|
2015-12-09 |
2022-11-22 |
金港医疗(澳大利亚)私人有限公司 |
用于治疗的免疫调节组合物
|
|
CA3012829A1
(en)
*
|
2016-01-27 |
2017-08-03 |
Advaxis, Inc. |
Personalized delivery vector-based immunotherapy and uses thereof
|
|
JP2019517522A
(ja)
*
|
2016-06-03 |
2019-06-24 |
エトゥビクス コーポレーション |
ヒトパピローマウイルス(hpv)関連疾患の処置のための組成物及び方法
|
|
SG11202008539YA
(en)
|
2018-03-06 |
2020-10-29 |
Precigen Inc |
Human papillomavirus vaccines and uses of the same
|
|
IL277128B2
(en)
|
2018-03-06 |
2025-11-01 |
Precigen Inc |
Hepatitis b vaccines and uses of the same
|